Clinical Trial: Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Sitagliptin for the Prevention and Treatment of Hyperglycemia in Patients With Type 2 Diabetes Undergoing Cardiac Surgery

Brief Summary: The purpose of this study is to determine whether treatment with sitagliptin reduces the frequency and severity of high blood sugar (hyperglycemia) after cardiac surgery and to determine whether treatment with sitagliptin is effective in maintaining blood sugar control in patients with type 2 diabetes (T2D).